News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
794,100 Results
Type
Article (54755)
Company Profile (319)
Press Release (739008)
Multimedia
Podcasts (183)
Webinars (32)
Section
Business (219245)
Career Advice (2679)
Deals (37179)
Drug Delivery (162)
Drug Development (85730)
Employer Resources (184)
FDA (17649)
Job Trends (16067)
News (370152)
Policy (35654)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (6)
Academia (2924)
Academic (1)
Accelerated approval (55)
ADA (48)
Adcomms (36)
Allergies (205)
Alliances (54188)
ALS (238)
Alzheimer's disease (1929)
Antibody-drug conjugate (ADC) (536)
Approvals (18070)
Artificial intelligence (821)
ASCO (335)
Autoimmune disease (362)
Automation (67)
Bankruptcy (371)
Best Places to Work (12211)
BIO (69)
BIOSECURE Act (22)
Biosimilars (241)
Biotechnology (209)
Bladder cancer (206)
Brain cancer (79)
Breast cancer (832)
Cancer (6521)
Cardiovascular disease (532)
Career advice (2284)
Career pathing (49)
CAR-T (374)
CDC (67)
Celiac Disease (3)
Cell therapy (1032)
Cervical cancer (57)
Clinical research (74545)
Collaboration (2359)
Commercialization (1)
Company closure (7)
Compensation (1508)
Complete response letters (92)
COVID-19 (2951)
CRISPR (123)
C-suite (1288)
Cystic fibrosis (164)
Data (8788)
Decentralized trials (3)
Denatured (67)
Depression (184)
Dermatology (97)
Diabetes (691)
Diagnostics (7407)
Digital health (69)
Diversity (13)
Diversity, equity & inclusion (47)
Drug discovery (407)
Drug pricing (225)
Drug shortages (34)
Duchenne muscular dystrophy (314)
Earnings (96812)
Editorial (79)
Employer branding (23)
Employer resources (165)
Events (129683)
Executive appointments (1177)
FDA (21745)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (36)
Funding (1955)
Gene editing (265)
Generative AI (77)
Gene therapy (815)
GLP-1 (1190)
Government (5215)
Grass and pollen (8)
Guidances (421)
Healthcare (20488)
Hematology (197)
HIV (94)
Huntington's disease (64)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (114)
Immunology and inflammation (330)
Immuno-oncology (108)
Indications (218)
Infectious disease (3337)
Inflammatory bowel disease (236)
Inflation Reduction Act (16)
Influenza (147)
Intellectual property (321)
Interviews (465)
IPO (17111)
IRA (55)
Job creations (4160)
Job search strategy (1883)
JPM (70)
Kidney cancer (21)
Labor market (113)
Layoffs (622)
Leadership (50)
Legal (8815)
Liver cancer (107)
Longevity (36)
Lung cancer (856)
Lymphoma (481)
Machine learning (68)
Management (64)
Manufacturing (1209)
Marketing (3)
MASH (220)
Medical affairs (1)
Medical device (14835)
Medtech (15010)
Mergers & acquisitions (21399)
Metabolic disorders (1741)
mRNA (257)
Multiple sclerosis (208)
NASH (20)
Neurodegenerative disease (500)
Neuropsychiatric disorders (118)
Neuroscience (3653)
Neurotech (1)
NextGen: Class of 2026 (7123)
Non-profit (4989)
Now hiring (82)
Obesity (810)
Opinion (346)
Ovarian cancer (243)
Pain (278)
Pancreatic cancer (360)
Parkinson's disease (416)
Partnered (39)
Patents (653)
Patient recruitment (781)
Peanut (70)
People (63947)
Pharmaceutical (69)
Pharmacy benefit managers (37)
Phase 1 (23219)
Phase 2 (32684)
Phase 3 (24452)
Pipeline (9971)
Policy (375)
Postmarket research (2868)
Preclinical (10121)
Press Release (69)
Prostate cancer (349)
Psychedelics (67)
Radiopharmaceuticals (362)
Rare diseases (1245)
Real estate (6493)
Recruiting (75)
Regulatory (27670)
Reports (59)
Research institute (2666)
Resumes & cover letters (432)
Rett syndrome (45)
RNA editing (28)
RSV (96)
Schizophrenia (188)
Series A (335)
Series B (248)
Service/supplier (13)
Sickle cell disease (125)
Special edition (29)
Spinal muscular atrophy (175)
Sponsored (52)
Startups (3944)
State (2)
Stomach cancer (20)
Supply chain (144)
Tariffs (93)
The Weekly (113)
Vaccines (1243)
Venture capital (135)
Weight loss (532)
Women's health (142)
Worklife (24)
Date
Last 7 days (462)
Last 30 days (2455)
Last 365 days (31620)
2026 (16690)
2025 (31588)
2024 (36618)
2023 (41555)
2022 (52855)
2021 (57641)
2020 (56409)
2019 (49677)
2018 (37584)
2017 (34563)
2016 (34612)
2015 (40685)
2014 (34808)
2013 (30359)
2012 (32264)
2011 (32652)
2010 (31046)
Location
Africa (956)
Alabama (98)
Alaska (7)
Arizona (377)
Arkansas (15)
Asia (44734)
Australia (7431)
California (14258)
Canada (4017)
China (1566)
Colorado (615)
Connecticut (639)
Delaware (439)
Europe (100449)
Florida (2139)
Georgia (464)
Hawaii (3)
Idaho (68)
Illinois (1198)
India (100)
Indiana (655)
Iowa (25)
Japan (609)
Kansas (141)
Kentucky (54)
Louisiana (59)
Maine (88)
Maryland (1708)
Massachusetts (10398)
Michigan (394)
Minnesota (782)
Mississippi (7)
Missouri (162)
Montana (36)
Nebraska (31)
Nevada (152)
New Hampshire (90)
New Jersey (3733)
New Mexico (34)
New York (3765)
North Carolina (1863)
North Dakota (11)
Northern California (7169)
Ohio (439)
Oklahoma (26)
Oregon (46)
Pennsylvania (2818)
Puerto Rico (33)
Rhode Island (53)
South America (1335)
South Carolina (87)
South Dakota (2)
Southern California (5642)
Tennessee (233)
Texas (2302)
United States (50731)
Utah (421)
Vermont (2)
Virginia (360)
Washington D.C. (84)
Washington State (1152)
West Virginia (4)
Wisconsin (139)
Wyoming (2)
794,100 Results for "social and scientific systems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Azenta Publishes 2025 Environmental, Social, and Governance (ESG) Report
May 22, 2026
·
4 min read
Press Releases
Vistagen Achieves Minimum ICH Safety Exposure Recommendations Across Clinical Program for Fasedienol for the Acute Treatment of Social Anxiety Disorder
June 9, 2026
·
9 min read
Neuropsychiatric disorders
Neuphoria’s Social Anxiety Drug Flunks Late-Stage Trial
The company is dropping its social anxiety disorder program but will still test the molecule in post-traumatic stress disorder.
October 21, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Real-World Example of Scientific Advancement Influence on Evaluation
April 23, 2026
·
6 min read
Press Releases
Vistagen Announces Completion of Last Patient Visit in PALISADE-4 Phase 3 Public Speaking Challenge Study of Fasedienol for Acute Treatment of Social Anxiety Disorder
May 8, 2026
·
10 min read
Press Releases
Inspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR Study
June 16, 2026
·
8 min read
Press Releases
Vistagen Announces Preliminary Positive Data in Ongoing Open-Label Extension Portion of PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder
May 12, 2026
·
13 min read
Press Releases
AtaiBeckley Announces Additional Phase 2a Results for EMP-01 (oral R-MDMA) Showing Large and Consistent Improvements in Social Anxiety Disorder
April 22, 2026
·
12 min read
Press Releases
CereVasc, Inc. Completes Enrollment in STRIDE Pivotal Trial of the eShunt® System
June 23, 2026
·
4 min read
Press Releases
Incyte and Edison Scientific Announce Strategic Collaboration to Employ the Kosmos AI Platform for Research and Development
May 19, 2026
·
4 min read
1 of 79,410
Next
